Detalles de la búsqueda
1.
Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer.
Oncologist;
28(3): 214-219, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36378560
2.
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma.
Esophagus;
20(3): 557-566, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631713
3.
Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies.
Oncologist;
27(6): 487-492, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278074
4.
Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma.
Oncology;
100(8): 439-448, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764050
5.
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer.
Eur J Nucl Med Mol Imaging;
49(3): 1012-1020, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34491404
6.
Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About.
J Natl Compr Canc Netw;
20(2): 193-202, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130503
7.
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study.
Dis Colon Rectum;
65(5): 642-653, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35067501
8.
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management.
Dis Colon Rectum;
65(2): 189-197, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990422
9.
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Oncology;
99(1): 49-56, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053548
10.
A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.
Invest New Drugs;
34(4): 450-7, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27075016
11.
Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
Invest New Drugs;
34(5): 575-83, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27289242
12.
Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT).
Invest New Drugs;
33(4): 895-900, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25937431
13.
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin.
Invest New Drugs;
32(6): 1269-77, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25213162
14.
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.
Invest New Drugs;
32(3): 542-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24526575
15.
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.
Mol Cancer Ther;
23(3): 394-399, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015561
16.
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial.
Clin Cancer Res;
2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727700
17.
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D.
Clin Colorectal Cancer;
2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762348
18.
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
Clin Colorectal Cancer;
2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653648
19.
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium.
Invest New Drugs;
31(4): 1008-15, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23354849
20.
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors.
Invest New Drugs;
31(5): 1182-91, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23860641